Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2021 Publisher: Opella Healthcare UK Limited, trading as Sanofi, 410 Thames Valley Park Drive, Reading, Berkshire, RG6 1PT, United Kingdom
Dulcoease 100 mg Capsules.
| Pharmaceutical Form |
|---|
|
Capsule, soft. A two colour (opaque white and opaque yellow) soft, oval, gelatin capsule with a clear, colourless liquid fill. |
Docusate sodium 100 mg.
Excipients of known effect:
Sorbitol
Sunset yellow (E110)
| Active Ingredient | Description | |
|---|---|---|
| Docusate |
Docusate is an anionic wetting agent, which acts as a faecal softener by lowering the surface tension and allowing penetration of accumulated hard dry faeces by water and salts. Docusate sodium also possesses stimulant activity. |
| List of Excipients |
|---|
|
Macrogol 400 |
PVC/PVdC blister packs with aluminium foil containing 10, 20, 30, 40, or 50 capsules.
Polyethylene/polypropylene containers, e.g.: securitainers/tampertainers containing 30, 100 and 250 capsules.
Not all pack sizes may be marketed.
Opella Healthcare UK Limited, trading as Sanofi, 410 Thames Valley Park Drive, Reading, Berkshire, RG6 1PT, United Kingdom
PL 53886/0022
06/10/2010
| Drug | Countries | |
|---|---|---|
| DULCOEASE | United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
